Investments and business

After more than two centuries, the American penny will be retired, closing a 238-year chapter in the nation’s monetary history. The final coin is set to be minted today at the US Mint in Philadelphia, marking the end of an era.The final minting and reasons for retirementThe last penny will be produced under the supervision of Treasury Secretary Scott Bessent and Treasurer Brandon Beach, following a directive from President Donald Trump earlier this year to halt production. The decision stems from the rising cost of manufacturing the coin—nearly four cents per penny—making it more expensive to produce than its actual…

President Donald Trump is considering issuing $2,000 tariff rebate checks to Americans as a way to offset rising costs, a move that has drawn both attention and scrutiny.The proposal to issue $2,000 stimulus payments emerges as persistent inflationary forces continue to burden household finances throughout the United States. The Trump administration has characterized this initiative as a direct response to the escalating costs of essential commodities, a situation partially linked to duties imposed on imported goods. These payments are intended to offer prompt financial assistance, enabling families to manage the rising expenses associated with food, electronics, and various other consumer…

Kimberly-Clark is set to acquire Tylenol’s parent company Kenvue in a nearly $50 billion deal, creating one of the largest consumer products conglomerates in the world. The merger combines a portfolio of household brands with global reach, but it also comes with notable financial and regulatory risks that both companies must navigate carefully.A pivotal consumer goods acquisitionThe integration of Kenvue, a company that originated from Johnson & Johnson in 2022, brings together renowned brands such as Tylenol, Johnson’s baby items, Clean & Clear, Kleenex, Listerine, and Depends under a single corporate entity, alongside Kimberly-Clark’s current product range. The organizations anticipate…

Kimberly-Clark is set to acquire Tylenol’s parent company Kenvue in a nearly $50 billion deal, creating one of the largest consumer products conglomerates in the world. The merger combines a portfolio of household brands with global reach, but it also comes with notable financial and regulatory risks that both companies must navigate carefully.A pivotal consumer goods acquisitionThe acquisition of Kenvue, which was spun off from Johnson & Johnson in 2022, unites iconic brands including Tylenol, Johnson’s baby products, Clean & Clear, Kleenex, Listerine, and Depends under one corporate umbrella alongside Kimberly-Clark’s existing portfolio. The companies project that the merger will…